SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001493152-24-045731
Filing Date
2024-11-14
Accepted
2024-11-14 15:14:10
Documents
1
Period of Report
2024-09-30
Effectiveness Date
2024-11-14

Document Format Files

Seq Description Document Type Size
1 formnt10-q.htm NT 10-Q 20468
  Complete submission text file 0001493152-24-045731.txt   21764
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
NEXIEN BIOPHARMA, INC. (Filer) CIK: 0001625288 (see all company filings)

IRS No.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
Type: NT 10-Q | Act: 34 | File No.: 000-55320 | Film No.: 241460834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)